Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for Blastocystis Hominis Infection
NCT01521403Phase 4Unknown
- Sponsor
- Lausanne University Hospital
- Start
- Nov 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Blastocystis hominis infection comparing Metronidazole with Placebo (2 arms). Primary endpoint: Improvement of gastro-intestinal symptoms. Status: unknown.
02
Drugs
metronidazole
03
Conditions
Blastocystis hominis infection
Beyond the preview
Go deeper on NCT01521403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01521403.